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Abstract
Human natural killer (NK) cell differentiation, characterized by a loss of NKG2A in parallel with the acquisition of NKG2C, KIRs,
and CD57 is stimulated by a number of virus infections, including infection with human cytomegalovirus (CMV), hantavirus,
chikungunya virus, and HIV-1. Here, we addressed if HSV-2 infection in a similar way drives NK cell differentiation towards an
NKG2A
-NKG2C
+KIR
+CD57
+ phenotype. In contrast to infection with CMV, hantavirus, chikungunya virus, and HIV-1, recurrent
HSV-2 infection did not yield an accumulation of highly differentiated NK cells in human peripheral blood. This outcome
indicates that human HSV-2 infection has no significant imprinting effect on the human NK cell repertoire.
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Introduction
Genital herpes simplex virus type 2 (HSV-2) infection is the
most common sexually transmitted ulcerative disease worldwide
[1]. The clinical presentation of HSV-2 infection ranges from
asymptomatic disease to recurrent and severe episodes of genital
and non-genital infection. Furthermore, recurrent HSV-2 infec-
tion is a major risk factor for the acquisition, transmission, and
progression of HIV-1 infection [1]. Adaptive cellular immunity has
been shown to be important in clearing HSV-2 infection both in
murine models and human studies [1]. Work from experimental
models of genital HSV-2 infection suggests that natural killer (NK)
cells may additionally be important in early control of infection
[1]. Interestingly, HSV-2 has been reported to disseminate in
humans during temporary episodes of NK cell deficiencies [1].
However, the impact of infection with HSV-2 on the NK cell
repertoire in humans has not been studied.
NK cells provide a first line of defense against many virus
infections [2]. In humans, the most convincing evidence for this
comes from patients with selective NK cell deficiencies. These
individuals often suffer from severe infections by viruses belonging to
the herpesvirus family [3]. Interestingly, many human herpesviruses
have also developed immune evasion mechanisms that specifically
target NK cells [2]. In experimental models, NK cells can recognize,
and have even been described to form memory against, cytomeg-
alovirus (CMV) [4]. In humans, infection by a multitude of viruses,
including CMV, hantavirus, chikungunya virus, and HIV-1 has
been reported to cause a shift in the NK cell repertoire towards an
accumulation of more terminally differentiated NK cells [5,6,7,8,9].
Such NK cell differentiation is characterized by a gradual shift from
more immature NKG2A
+CD62L
+CD57
2KIR
2CD56
bright NK
cells to NKG2A
+/2CD62L
+/2CD57
2/+KIR
2/+CD56
dim interme-
diates that progress further towards terminally differentiated
NKG2A
2CD62L
-CD57
+KIR
+CD56
dim NK cells [10,11,12]. This
NK cell differentiation is associated with multiple phenotypic and
functional changes, including low expression of cytokine- and
chemokine-receptors, a gradual decline in proliferative capacity and
responsiveness to cytokines, and increased ability to perform
cytotoxic responses [10,11,12].
In the current study, we examined the phenotype and function
of NK cells and, furthermore, specifically addressed whether a
HSV-2 infection could drive the human NK cell repertoire
towards an accumulation of terminally differentiated
NKG2A
-NKG2C
+KIR
+CD57
+ cells as has been observed in
other human viral infections.
Results
Characterization of NK cell differentiation status during
recurrent HSV-2 infection
To characterize the phenotype and function of human NK cells,
and to specifically study if HSV-2 infection drives human NK cell
differentiation, peripheral blood was obtained from patients with
recurrent genital herpes as well as from healthy, asymptomatic,
HSV-2 seropositive individuals. On this material, we performed a
detailed characterization of NK cells using multi-color flow
cytometry, assessing the phenotype, functionality, and differenti-
ation status of ex vivo isolated peripheral blood NK cells. The
results allowed us to evaluate specifically if recurrent HSV-2
infections led to changes in the NK cell repertoire compared to a
latent asymptomatic infection. Patients with recurrent HSV-2
infection and HSV-2 seropositive controls had equal numbers of
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bright NK cells
out of total NK cells (Fig. 1A and 1B). Early and late differentiated
NK cells can be identified by expression patterns of NKG2A and
CD57 [10,12]. More immature CD56
bright NK cells are uniformly
NKG2A
+CD57
2, whereas CD56
dim NK cell differentiation is
characterized by the gradual loss of NKG2A coupled to the
acquisition of CD57 [10,12]. In the present study groups,
expression patterns of NKG2A and CD57 on CD56
dim NK cells
from patients with recurrent HSV-2 infection were strikingly
similar to those of NK cells from HSV-2 seropositive healthy
individuals (Fig. 1A and 1D). Furthermore, inhibitory LILRB1
and activation receptors NKG2D and NKp46, which are also
altered during NK cell differentiation [10,11,12], remained
unaffected when comparing the two groups (Fig. 1A, 1C, and
1D). These findings contrast with those from patients with, e.g.,
HIV-1, chikungunya virus, or hantavirus infection in whom the
infections drive the increased accumulation of highly differentiated
NK cells [6,7,9].
From our investigation of NKG2C expression in patients with
recurrent HSV-2 infection, on average 10% (range 4% to 25%) of
their CD56
dim NK cells expressed the receptor (Fig. 1A and 1D).
However, no specific expansion of NKG2C
+ NK cells was
detected in the patients as compared to the HSV-2 seropositive
healthy individuals (Fig. 1D). The CMV serostatus was not
Figure 1. Characterization of NK cell differentiation in symptomatic HSV-2 infected patients. (A) Representative stainings for
identification of CD56
bright NK cells, and NKG2A-, CD57-, NKG2C-, LILRB1-, NKp46-, and NKG2D-positive CD56
dim NK cells in PBMC from one patient
with recurrent HSV-2 infection. For NKp46 and NKG2D, solid grey histograms display isotype controls and black lines display the respective specific
stainings. (B) Frequency of NK cells out of total lymphocytes and CD56
bright NK cells out of total NK cells. (C) Expression levels (mean fluorescence
intensity, MFI) of NKG2D and NKp46 on CD56
dim NK cells. (D) Expression (%) of NKG2A, NKG2C, CD57, and LILRB1 on CD56
dim NK cells. In (B) through
(D), closed circles represent asymptomatic (AS) HSV-2 seropositive individuals (n=6) and open circles represent patients with recurrent (S) HSV-2
infection (n=9). In (B) through (D), the Mann-Whitney rank sum test was used, n.s., not significant, bars represent mean.
doi:10.1371/journal.pone.0027664.g001
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analysis of NKG2C expression. This issue remains unresolved,
since previous work associated expression of the activation
receptor NKG2C on NK cells with human CMV infection, and
no other herpesvirus has, per se, been linked to enhanced NKG2C
expression [5]. Furthermore, previous reports have shown that
CMV serostatus affects the frequency of NKG2C
+ NK cells in
patients with HIV-1 [13]. Nevertheless, the presence of NKG2C
+
NK cells in all subjects investigated in this study would argue for a
high prevalence of CMV in both groups (Fig. 1D).
The KIR repertoire of CD56
dim NK cells remain intact in
recurrent HSV-2 infection
Inhibitory KIR (killer cell immunoglobulin-like receptor)
expression on NK cells is primarily confined to the CD56
dim
NK cell subset [10]. NK cell differentiation is associated with a
sequential acquisition of KIRs [10,11,12]. Except for preserving
tolerance and regulating NK cell recognition of target cells, NK
cells must express at least one inhibitory KIR with a self-ligand
present in the host to become educated [14]. Here, we investigated
both the KIR specificity (i.e., expression of individual KIRs) and
the KIR distribution pattern (i.e., the combination in which KIRs
are expressed) by using three different anti-KIR antibodies for co-
staining of CD56
dim NK cells from the patients with recurrent
HSV-2 infection (Fig. 2A). NK cells from these patients showed a
variegated KIR expression (Fig. 2B) with, amongst the KIR
+ cells,
a dominance of single KIR-expressing cells (Fig. 2C). This pattern
was similar to the KIR profile of the HSV-2 seropositive healthy
individuals (Fig. 2B and 2C). Furthermore, the two groups had on
average 50% KIR-negative NK cells (Fig. 2C). These data provide
additional evidence that no differentiated NK cells accumulated
during recurrent HSV-2 infection, as they did in the other viral
infections described above. For instance, this pattern contrasts
with that of the KIR profile for the differentiated NKG2C
+CD57
+
NK cells that expand during acute hantavirus infection. In these
hantavirus-infected individuals, the expanded NK cells had a
profile that was skewed towards expression of a single inhibitory
KIR [7].
NK cell degranulation capacity is intact during recurrent
HSV-2 infection
Finally, to address if a possible defect in NK cell degranulation
might represent one factor behind recurrent HSV-2 infection, the
capacity of resting unmanipulated NK cells to degranulate against
K562 target cells after a six-hour co-incubation time was evaluated
by assessment of CD107a expression (Fig. 3A). NK cells from
patients with recurrent HSV-2 infection were equally efficient as
NK cells from HSV-2 seropositive healthy individuals in
upregulating CD107a (Fig. 3B). Thus, unlike the degranulation
defects seen in some patient groups with familial hemophagocytic
lymphohistiocytosis [15], NK cells from patients with recurrent
HSV-2 infection seem to have an intact capacity to degranulate.
Discussion
Several limitations of our study have to be considered. First, one
explanation for the unaltered NK cell differentiation status found
in peripheral blood of patients with recurrent HSV-2 infection
might be that HSV-2 exerts only local effects in the genital
mucosa. Support for this conclusion comes from studies of patients
with celiac disease [16]. There, only intraepithelial CD8 T cells in
the gut lumen, i.e., at the site of inflammation, became activated
and expressed high levels of NKG2C, whereas the corresponding
T cells in peripheral blood were unaffected [16]. Thus, we cannot
Figure 2. KIR expression on NK cells from symptomatic HSV-2 patients. (A) Representative stainings for KIR2DL1-, KIR2DL3-, and KIR3DL1-
positive CD56
dim NK cells from one patient with recurrent HSV-2 infection. (B) KIR expression on CD56
dim NK cells. (C) Frequency of CD56
dim NK cells
expressing 0, 1, 2, or 3 KIRs, as determined after a Boolean gating analysis for KIR2DL1, KIR2DL2/3, and KIR3DL1. In (B) and (C), closed circles represent
asymptomatic (AS) HSV-2 seropositive individuals (n=6) and open circles represent patients with recurrent (S) HSV-2 infection (n=9). In (B) and (C),
the Mann-Whitney rank sum test was used, n.s., not significant, bars represent means.
doi:10.1371/journal.pone.0027664.g002
NK Cells in HSV-2 Infection
PLoS ONE | www.plosone.org 3 November 2011 | Volume 6 | Issue 11 | e27664exclude that tissue-resident NK cells are differentiating in response
to HSV-2 infection. A characterization of genital mucosa-
associated NK cells during recurrent HSV-2 infection might
reveal a different pattern of NK cell differentiation.
Second, we did not have access to clinical data documenting
when the patients with recurrent HSV-2 infection had their last
episode of infection. It is possible that signs of NK cell
differentiation occur only transiently in conjunction with active
infection. However, during both acute hantavirus and acute
chikungunya virus infections [7,9], and during CMV reactivation
[8], alterations in the NK cell repertoire are evident in peripheral
blood months after infection.
Third, since HSV-2 in most individuals is a lifelong latent
infection, the absence of a HSV-2 seronegative group of healthy
individuals in the study design precluded our ability to test for NK
cell differentiation changes that occurred solely as a consequence
of HSV-2 serostatus. Instead, our study focused on determining
the impact of recurrent HSV-2 infections, defined as six or more
annual episodes of clinical disease, on the NK cell repertoire.
Whereas changes in the NK cell repertoire attributed to HSV-2
serostatus, per se, have not been analyzed in detail before, it has
been shown that neither HSV-1 nor Epstein-Barr virus serostatus
has had any major impact on the expression of NKG2C;
furthermore, CMV serostatus causes no alterations in KIR or
LILRB1 expression [5].
In summary, this study of recurrent HSV-2 infection in humans
revealed a distinct difference from the outcome of infection with
human CMV, hantavirus, chikungunya virus, or HIV-1 [5,6,7,9],
all of which can drive NK cell differentiation towards the
accumulation of terminal effector cells. Instead, the data suggest
that HSV-2 infection, in contrast to other infections, leaves the
NK cell repertoire unaltered.
Materials and Methods
Ethics statement
All included patients and healthy individuals gave written
informed consent to participate in the study and the Ethics
Committee of the University of Gothenburg, Sweden, granted
permission for the study.
Patient material
Blood samples were obtained from patients with recurrent
HSV-2 infection were obtained. These patients had a typical
history of recurrent genital herpes, with six or more annual
relapses of infection. As controls, asymptomatic HSV-2 seropos-
itive individuals were recruited during routine screenings. The
latter HSV-2 seropositive healthy individuals were interviewed
thoroughly before being classified as asymptomatic carriers. HSV-
2 seropositivity was verified by ELISA in both groups. Peripheral
blood mononuclear cells (PBMC) were isolated from whole fresh
blood of both groups by centrifugation on Ficoll-Hypaque and
were vitally frozen in 95% fetal calf serum and 5% DMSO in
liquid nitrogen for later usage.
ELISA for detection of HSV-2 specific antibodies
Plasma was screened for HSV-2 specific antibodies using ELISA
as described [17].
Phenotyping of NK cells by flow cytometry
Flow cytometry stainings were performed as previously
described on thawed PBMC [18]. Briefly, Fc receptors were
blocked using 0.5mg/ml of intravenous immunoglobulin for 20
min on ice. Next, ethidium monoazide bromide was added (1 mg/
ml), and the cells were incubated 10 min on ice in the dark
followed by a 10 min exposure to bright light on ice for later
visualization of dead cells. Finally, cells were stained with
saturating amounts of the desired monoclonal antibody (mAb)
combination and incubated 20 min on ice in the dark. Data were
acquired on a CyAn
TM ADP LX 9-color flow cytometer and
analyzed with FlowJo software version 9.3. Commercially
available mAbs against the following proteins were used: NKG2A,
KIR2DL1, KIR2DL2/3, KIR3DL1, CD57, NKG2C, LILRB1,
NKp46, NKG2D, CD56, CD3, and CD14.
Degranulation assay
For analysis of NK cell function, CD107a degranulation assays
were performed as previously described [19]. Briefly, thawed
PBMC that had been rested over night in complete medium at
37uC were cocultured with K562 target cells (American Type
Culture Collection, Manassas, VA, USA) at a 10:1 E:T ratio for six
hours. A commercially available mAb against CD107a was added
at the start of the assay. Monensin was added after one hour of
coculture. After six hours, the samples were stained with mAbs
against CD56, CD3, and CD14, and immediately acquired, as
described above.
Statistical analysis
Statistical analysis was performed using Graphpad software
version 5.0, and the Mann-Whitney rank sum test was performed.
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Figure 3. NK cells from patients with symptomatic HSV-2
infection retain their capacity to degranulate. (A) Representative
staining for CD107a expression on unstimulated and K562 target cell-
stimulated NK cells from one patient with symptomatic HSV-2 infection.
(B) Level of CD56
dim NK cell degranulation against K562 cells for
asymptomatic (AS) HSV-2 seropositive individuals (n=5) and patients
with recurrent (S) HSV-2 infection (n=5). The Mann-Whitney rank sum
test was used, n.s., not significant, bars represent means.
doi:10.1371/journal.pone.0027664.g003
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